# Observation of Treatment With Certolizumab Pegol in Daily Practice

> **NCT01069419** · — · COMPLETED · sponsor: **UCB Pharma GmbH** · enrollment: 1117 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01069419
- **Lead sponsor:** UCB Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2014-09
- **Final completion:** 2014-12
- **Target enrollment:** 1117 (ACTUAL)
- **Last updated:** 2015-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01069419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01069419, "Observation of Treatment With Certolizumab Pegol in Daily Practice". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01069419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*